Look for New Risk Categories and Beyond-Use Dates With USP 797

NOTICE (September 2019): After this article was published, USP postponed the official dates of the revised <795> and <797> chapters until further notice. Please see their notice here.

The clock is ticking for your hospital to update sterile compounding policies to comply with the latest USP <797> standards.

Be prepared for changes by the "go-live" date...December 1, 2019.

Risk categories and beyond-use dates (BUDs). Be aware that the low-, medium-, and high-risk compounding categories will be replaced by Category 1 and 2. These new designations focus on where the prep is made.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals